CLIN

S08--Rethinking Pulmonary Management in the Current Era of CF | Room: Ballroom 2 (Level 5)

Chair(s)

• 

  Don Sanders, MD

  Pediatrics
  Riley Hospital for Children at Indiana University Health
• 

  Georgene Hergenroeder, MD

  Children's Hospital of Philadelphia, Division of Pulmonary and Sleep Medicine

This session will highlight how pulmonary exacerbations (PEx) and PEx management have changed in the era of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy. A particular emphasis will be placed on the experience of a person with CF with the burden of care and PEx following modulator initiation, changes in management of PEx from an adult and pediatric perspective, and the need for decentralized studies to study treatment de-escalation in the post-modulator era.

Presentations:

• 2:30 PM - 4:30 PM PDT

  S08.1- Patient Perspective
  

  Community Speaker: Kaylee Alvarado – n/a
• 2:30 PM - 4:30 PM PDT

  S08.2- Management of Pulmonary Exacerbations in the Post ETI Era
  

  Speaker: Christopher Goss, MD – University of Washington
• 2:30 PM - 4:30 PM PDT

  S08.3- Changes in Pulmonary Exacerbations in Children with CF
  

  Speaker: Michael S. Schechter, MD, MPH – Children’s Hospital of Richmond at Virginia Commonwealth University
• 2:30 PM - 4:30 PM PDT

  S08.4- HERO-2: Decentralized Trials to Study De-escalation
  

  Speaker: Clement Ren, MD – Children's Hospital of Philadelphia